Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis - PubMed
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis
Matthew D Rutter et al. Gastroenterology. 2006 Apr.
Abstract
Background & aims: The value of colonoscopic surveillance for neoplasia in long-standing extensive ulcerative colitis remains controversial. This study reports on prospectively collected data from a surveillance program over a 30-year period.
Methods: Data were obtained from the prospective surveillance database, medical records, colonoscopy, and histology reports. The primary end point was defined as death, colectomy, withdrawal from surveillance, or census date (January 1, 2001). Follow-up information was obtained for patients who left the program.
Results: Six hundred patients underwent 2627 colonoscopies during 5932 patient-years of follow-up. The cecal intubation rate was 98.7%, with no significant complications. Seventy-four patients (12.3%) developed neoplasia, including 30 colorectal cancers (CRCs). There was no difference in median age at onset of colitis for those with or without CRC (P = .8, Mann-Whitney). The cumulative incidence of CRC by colitis duration was 2.5% at 20 years, 7.6% at 30 years, and 10.8% at 40 years. The 5-year survival rate was 73.3%. Sixteen of 30 cancers were interval cancers. CRC incidence decreased over time (r = -.40, P = .04; linear regression).
Conclusions: Colonoscopic surveillance is safe and allows the vast majority of patients to retain their colon. Although two thirds of patients with potentially life-threatening neoplasia benefited from surveillance, the program was not wholly effective in cancer prevention. The cancer incidence, however, was considerably lower than in the majority of other studies, and was constant for up to 40 years of colitis duration, suggesting there is no need to intensify surveillance over time.
Comment in
-
The changing face of colorectal cancer in inflammatory bowel disease: progress at last!
Rubin DT. Rubin DT. Gastroenterology. 2006 Apr;130(4):1350-2. doi: 10.1053/j.gastro.2006.03.015. Gastroenterology. 2006. PMID: 16618426 No abstract available.
Similar articles
-
Lindberg J, Stenling R, Palmqvist R, Rutegård J. Lindberg J, et al. J Pediatr Gastroenterol Nutr. 2008 May;46(5):534-8. doi: 10.1097/MPG.0b013e31815a98ef. J Pediatr Gastroenterol Nutr. 2008. PMID: 18493208
-
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Rubin DT, et al. Gastrointest Endosc. 2007 Jun;65(7):998-1004. doi: 10.1016/j.gie.2006.09.025. Epub 2007 Apr 23. Gastrointest Endosc. 2007. PMID: 17451704
-
Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL. Lakatos L, et al. Orv Hetil. 2006 Jan 29;147(4):175-81. Orv Hetil. 2006. PMID: 16515026 Hungarian.
-
Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK. Rex DK. Am J Gastroenterol. 1995 Mar;90(3):353-65. Am J Gastroenterol. 1995. PMID: 7872270 Review.
-
Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Smith RA, Lieberman DA, Burt RW, Levin TR, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK; US Multi-Society Task Force on Colorectal Cancer; American Cancer Society. Winawer SJ, et al. Gastroenterology. 2006 May;130(6):1872-85. doi: 10.1053/j.gastro.2006.03.012. Gastroenterology. 2006. PMID: 16697750 Review.
Cited by
-
Hirata I. Hirata I. Clin J Gastroenterol. 2008 Dec;1(4):139-144. doi: 10.1007/s12328-008-0043-y. Epub 2008 Dec 5. Clin J Gastroenterol. 2008. PMID: 26193691
-
Wound repair: role of immune-epithelial interactions.
Leoni G, Neumann PA, Sumagin R, Denning TL, Nusrat A. Leoni G, et al. Mucosal Immunol. 2015 Sep;8(5):959-68. doi: 10.1038/mi.2015.63. Epub 2015 Jul 15. Mucosal Immunol. 2015. PMID: 26174765 Free PMC article. Review.
-
Kottachchi D, Yung D, Marshall JK. Kottachchi D, et al. Can J Gastroenterol. 2009 Sep;23(9):613-7. doi: 10.1155/2009/691850. Can J Gastroenterol. 2009. PMID: 19816624 Free PMC article.
-
Haberman Y, Karns R, Dexheimer PJ, Schirmer M, Somekh J, Jurickova I, Braun T, Novak E, Bauman L, Collins MH, Mo A, Rosen MJ, Bonkowski E, Gotman N, Marquis A, Nistel M, Rufo PA, Baker SS, Sauer CG, Markowitz J, Pfefferkorn MD, Rosh JR, Boyle BM, Mack DR, Baldassano RN, Shah S, Leleiko NS, Heyman MB, Grifiths AM, Patel AS, Noe JD, Aronow BJ, Kugathasan S, Walters TD, Gibson G, Thomas SD, Mollen K, Shen-Orr S, Huttenhower C, Xavier RJ, Hyams JS, Denson LA. Haberman Y, et al. Nat Commun. 2019 Jan 3;10(1):38. doi: 10.1038/s41467-018-07841-3. Nat Commun. 2019. PMID: 30604764 Free PMC article.
-
Colorectal carcinoma in the course of inflammatory bowel diseases.
Hnatyszyn A, Hryhorowicz S, Kaczmarek-Ryś M, Lis E, Słomski R, Scott RJ, Pławski A. Hnatyszyn A, et al. Hered Cancer Clin Pract. 2019 Jul 12;17:18. doi: 10.1186/s13053-019-0118-4. eCollection 2019. Hered Cancer Clin Pract. 2019. PMID: 31338130 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical